The $125 billion question: how will the ACA affect cancer survivors?
In 2010, the total cost of cancer care in the United States reached $125 billion. Cancer patients are also living longer today, which is further increasing the cost of their continued care. As the health insurance exchanges have opened and heated debate about the Affordable Care Act (ACA) continues, many questions remain, including the $125 billion question: “How will the ACA affect the most expensive disease: cancer?”
And the award goes to…
Once again, numerous VCU Massey Cancer Center physicians were recognized as “Top Docs” in Richmond Magazine’s April 2014 issue. The list included 20 doctors from multiple specialties who provide care to Massey’s patients. The selections were the result of a survey that asked Richmond-area physicians who they would recommend in a range of specialties. The following Massey physicians were named as top performers in their respective categories.
Researchers uncover allergy-cancer connection
While many are stocking up on allergy medicine in preparation for spring, a new study from researchers at Virginia Commonwealth University Massey Cancer Center has uncovered a new connection between allergy and cancer that could potentially lead to therapies involving common antihistamines.
VCU welcomes new clinical research services executive director
Fredika A. Robertson, Ph.D., has joined Virginia Commonwealth University as its new executive director of Clinical Research Services (CRS) for the Center for Clinical and Translational Research (CCTR). She is also a professor in the Department of Internal Medicine in the VCU School of Medicine and a member of the Developmental Therapeutics research program at VCU Massey Cancer Center.
Massey on the Radio: Dr. Mark Malkin
Massey neuro-oncologist Mark G. Malkin, took to the airwaves recently to discuss his field and why he believes in the Massey difference.
Colorectal cancer is preventable and treatable
March is National Colorectal Cancer Awareness Month and, although the incidence rates for the disease have decreased, overall lifetime risk of developing colorectal cancer is 1 in 20, making it the third most common cancer in both men and women. The good news is that due to screening and treatment advances, colorectal cancer is one of the most preventable and treatable types of cancer. As a result, there are now more than 1 million colorectal cancer survivors in the United States.